Flash forward: a review of flash glucose monitoring
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The FreeStyle Libre flash glucose monitor became available on prescription (subject to local health authority approval) in all four nations of the UK from November 2017, a watershed moment in the history of diabetes care. Calibration free, the FreeStyle Libre is a disc worn on the arm for 14 days which is designed largely to replace the recommended 4–10 painful finger‐stick blood glucose tests required each day for the self‐management of diabetes. This review discusses clinical data from randomized and observational studies, considers device accuracy metrics and deliberates its popularity and the potential challenges that this new device brings to diabetes care in the UK. In randomized trials, FreeStyle Libre use is associated with a reduction in hypoglycaemia and, in observational studies, improvements in HbA 1c levels. User satisfaction is high and adverse events are low. Accuracy of the FreeStyle Libre is comparable to currently available real‐time continuous glucose monitors in adults, children and during pregnancy; the cost of the FreeStyle Libre is lower. Glucose data can be visualized in multiple devices and platforms, and summarized in an ambulatory glucose profile to aid pattern recognition and insulin dose adjustment. There is a need for appropriate education, of both users and healthcare professionals, to harness the full benefits. Further randomized studies to assess the long‐term impact on HbA 1c, particularly in those with high baseline HbA 1c and in specific age groups, such as adolescents and young adults, are warranted. The potential impact on complications, is yet to be realized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 1×
“[31] assessed the accuracy of the FreeStyle Libre in 72 study participants with Type 1 or Type 2 diabetes at four clinical sites in the USA.”
MethodParkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307 · cited 1×
“An expert group in the USA concluded that standardization of CGM data reporting using the ambulatory glucose profile would be of benefit [45] Matthaei et al.”
BackgroundReddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245 · cited 1×
“[12], the FreeStyle Libre was assessed compared with real-time CGM (Dexcom G5) in people with Type 1 diabetes who had experienced a severe hypoglycaemic event in the last 12 months or had impaired awareness of hypoglycaemia (Gold score ≥4).”
MethodHerman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Comparative accuracy of 17 point-of-care glucose meters
Ekhlaspour, L., Mondesir, D., Lautsch, N., Balliro, C., Hillard, M., Magyar, K., Radocchia, L. G., Esmaeili, A., Sinha, M., & Russell, S. J. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816672237 · Cited by 127 · cited 1×
“[36] assessed 17 different commercially available glucose meters against the Yellow Springs reference method (YSI 2300) to determine the mean ARD.”
MethodClinical Implications of Accuracy Measurements of Continuous Glucose Sensors
Bailey, T. S. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0050 · Cited by 60
Cited by
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Shan, R., Sarkar, S., & Martin, S. S. (2019) · Diabetologia · doi:10.1007/s00125-019-4864-7 · Cited by 339
Kristensen, K., Ögge, L. E., Sengpiel, V., Kjölhede, K., Dotevall, A., Elfvin, A., Knop, F. K., Wiberg, N., Katsarou, A., Shaat, N., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4850-0 · Cited by 210
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Teo, E., Hassan, N., Tam, W., & Koh, S. (2022) · Diabetologia · doi:10.1007/s00125-021-05648-4 · Cited by 186
Metadata
- Authors
- Leelarathna, L., & Wilmot, E. G.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2018-02-27
- Volume
- 35
- Issue
- 4
- Pages
- 472-482
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2790387712
- Cited by
- 167
- References
- 11
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.